Pharma Stocks
-
Where are these stocks headed? – Tata Technologies, Aurobindo Pharma, ACC, Electronics Mart India Limited (EMIL)
I have bought Tata Technologies shares at ₹1,030. What is the technical outlook for this stock? Gunashekar P, Chennai Tata…
Read More » -
Shionogi (TSE:4507) Infectious Disease Progress Keeps Valuation Questions In Play
Why Shionogi stock is back on infectious disease investors’ radar Shionogi (TSE:4507) has drawn fresh attention after Japan approved a…
Read More » -
Trading of Beximco Pharma GDRs resumes on London Stock Exchange
Beximco Pharmaceuticals had its GDRs suspended from trading on 2 January after failing to publish its audited financial statements. TBS…
Read More » -
Why Eli Lilly Stock Jumped to a New All-Time High Today
Shares of Eli Lilly (LLY +7.51%) climbed to a record high on Friday, following several promising developments for the medicine…
Read More » -
Why Acadia Pharmaceuticals Stock Is Soaring Today
Key Points Acadia Pharmaceuticals focuses on underserved rare diseases. Although they’re (by definition) small markets, there’s often little to no…
Read More » -
Amylyx Pharmaceuticals (AMLX) Reports Early LUMINA Safety Data, Is The Stock Still Below Fair Value?
Amylyx Pharmaceuticals (AMLX) is back in focus after presenting early Phase 1 LUMINA trial data for its ALS candidate AMX0114…
Read More » -
REG – AIM Beximco Pharma. – Restoration
RNS Number : 9334J AIM 26 June 2026 NOTICE 26/06/2026 7:30am RESTORATION OF TRADING ON AIM BEXIMCO PHARMACEUTICALS PLC…
Read More » -
Is It Worth Considering Chugai Pharmaceutical Co., Ltd. (TSE:4519) For Its Upcoming Dividend?
It looks like Chugai Pharmaceutical Co., Ltd. (TSE:4519) is about to go ex-dividend in the next two days. The ex-dividend…
Read More » -
Helus Pharma Announces Closing of US$50 Million Underwritten Offering
Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical stage pharmaceutical company committed to helping…
Read More » -
3 Under-the-Radar Biotech Takeover Targets for the Next Pharma Buying Spree
Large-cap pharma is back in the deal market. AbbVie’s (NASDAQ: ABBV | ABBV Price Prediction) pending acquisition of Apogee Therapeutics…
Read More »